Securities code: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) securities abbreviation: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) Announcement No.: 2022028 Tibet Duo Rui Pharmaceutical Co.Ltd(301075)
Announcement of resolutions of the 9th meeting of the 1st board of supervisors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) (hereinafter referred to as "the company") the notice of the ninth meeting of the first session of the board of supervisors was sent by email and wechat on March 12, 2022, and was held in the company's conference room on March 23, 2022 in the form of on-site combined with communication voting. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. This meeting was convened and presided over by Mr. Zhao Hongwei, chairman of the board of supervisors. The convening and convening of the meeting shall comply with the provisions of the company law of the people's Republic of China, the securities law of the people's Republic of China and other laws, administrative regulations, departmental rules, normative documents and the articles of association. After deliberation by the supervisors attending the meeting, the following resolutions are formed. 2、 Deliberation at the meeting of the board of supervisors
(I) deliberated and adopted the work report of the board of supervisors in 2021
After deliberation, the board of supervisors adopted the work report of the board of supervisors in 2021.
See details published on cninfo.com.cn on the same day Annual report of the board of supervisors 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(II) deliberating and adopting the 2021 annual report and its summary
After deliberation, the board of supervisors considered that the preparation procedure, content and format of the company's annual report 2021 and its summary were in line with the provisions of relevant documents; The contents of the report truly, accurately and completely reflect the actual situation of the company, and there are no false records, misleading statements or major omissions.
See details published on cninfo.com.cn on the same day Annual report of 2021 (Announcement No.: 2022018) and summary of annual report of 2021 (Announcement No.: 2022019).
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(III) review and approve the financial final accounts report of 2021
After deliberation, the board of supervisors approved the 2021 annual financial statement report. For details, please refer to section X "financial report" of the company's 2021 annual report.
See details published on cninfo.com.cn on the same day Annual report of 2021 (Announcement No.: 2022018).
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(IV) review and approve the profit distribution plan for 2021
After deliberation, the board of supervisors considered that the company's 2021 profit distribution plan complies with the relevant provisions on dividends in the company law, the securities law and the articles of association, the company's shareholders' long-term return plan and relevant commitments, the dividend distribution policy, and the 2021 profit distribution plan has legitimacy, compliance and rationality.
Independent directors have expressed their independent opinions on this proposal.
See details published on cninfo.com.cn on the same day Announcement on profit distribution plan in 2021 (Announcement No.: 2022020). Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(V) the special report on the annual deposit and use of raised funds was reviewed and approved. After deliberation, the board of supervisors considered that in 2021, the company deposited and used the raised funds from initial public offering in strict accordance with relevant laws, regulations, normative documents and the relevant provisions of the company's raised funds management system, which was in line with the relevant provisions of the CSRC and Shenzhen Stock Exchange on the deposit and use of raised funds of listed companies, There is no situation of changing the investment direction of the raised funds in a disguised form and damaging the interests of shareholders. The special report of the board of directors on the annual storage and use of raised funds truthfully, accurately and completely disclosed the storage and use of the company's raised funds, and the company faithfully fulfilled its obligation to disclose the investment direction and progress of the raised funds. The independent directors have expressed their independent opinions on this proposal, the audit institution Tianjian Certified Public Accountants (special general partnership) has issued an assurance report, and the sponsor Citic Securities Company Limited(600030) has issued special verification opinions.
See details published on cninfo.com.cn on the same day Relevant announcements on.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(VI) deliberating and adopting the self-evaluation report on internal control in 2021
After deliberation, the board of supervisors considered that the self-evaluation report on internal control in 2021 objectively and truly reflected the implementation of the company's internal control in 2021, and considered that the company had no major defects in internal control over financial reports, and no major defects in internal control over non-financial reports were found. The independent directors have expressed their independent opinions on this proposal, the audit institution Tianjian Certified Public Accountants (special general partnership) has issued an assurance report, and the sponsor Citic Securities Company Limited(600030) has issued special verification opinions.
See details published on cninfo.com.cn on the same day Self evaluation report on internal control in 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
(VII) deliberated and passed the proposal on the renewal of the company's audit institution in 2022
After deliberation, the board of supervisors agreed to renew the appointment of Tianjian Certified Public Accountants (special general partnership) as the audit institution of the company in 2022, and authorized the management to determine its annual audit fee according to the specific workload and market price level of the audit in 2022 for a period of one year.
The independent directors gave their prior approval opinions and expressed their independent opinions with explicit consent to this proposal.
See details published on cninfo.com.cn on the same day Announcement on the proposed renewal of accounting firm (Announcement No.: 2022021).
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(VIII) deliberation and approval of the proposal on changes in accounting policies
After deliberation, the board of supervisors agreed that the company's implementation of the revised accounting standards for Business Enterprises No. 21 - leasing was carried out in accordance with the provisions of relevant documents of the Ministry of Finance and in line with the provisions of relevant laws and regulations. After the implementation of the changed accounting policies, the company's financial situation and operating results can be reflected objectively and fairly, without retroactive adjustment of previous years, and the company's financial situation Operating results and cash flow will not have a significant impact. There is no damage to the interests of the company and minority shareholders.
Independent directors have expressed their independent opinions on this proposal.
Voting results: 3 in favor, 0 against and 0 abstention.
(IX) the proposal on the confirmation of recurring related party transactions in 2021 was reviewed and approved. After deliberation, the board of supervisors confirmed the company's recurring related party transactions in 2021.
The independent directors of the company have expressed their prior approval opinions on this matter and expressed their independent opinions with explicit consent to this proposal; The recommendation institution Citic Securities Company Limited(600030) issued special verification opinions.
See details published on cninfo.com.cn on the same day Announcement on confirmation of related party transactions in 2021 (Announcement No.: 2022023).
Voting results: 3 in favor, 0 against and 0 abstention.
(x) deliberated and passed the proposal on confirmation of related party guarantee in 2021
After deliberation, the board of supervisors confirmed the related guarantee of the company in 2021.
The independent directors of the company have expressed their prior approval opinions on this matter and expressed their independent opinions with explicit consent to this proposal; The recommendation institution Citic Securities Company Limited(600030) issued special verification opinions.
See details published on cninfo.com.cn on the same day Announcement on confirmation of related party transactions in 2021 (Announcement No.: 2022023).
Voting results: 3 in favor, 0 against and 0 abstention.
3、 Documents for future reference
(I) resolutions of the ninth meeting of the first board of supervisors. It is hereby announced.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) board of supervisors March 24, 2022
